The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms (Q26823825)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Stanley Nattel

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

Dobromir Dobrev

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

2

Paul Khairy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

1 reference

25 April 2014

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

114

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

9

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

1453-1468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

Impact of atrial fibrillation on mortality, stroke, and medical costs

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Alcohol and risk of atrial fibrillation or flutter: a cohort study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Risk of new-onset atrial fibrillation in relation to body mass index

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Comparative Effectiveness of Rhythm Control vs Rate Control Drug Treatment Effect on Mortality in Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Sodium channel mutations and susceptibility to heart failure and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Pulse pressure and risk of new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Anticoagulants for atrial fibrillation: why is the treatment rate so low?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Evaluation of costs and outcome in cardioembolic stroke or TIA

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Diabetes mellitus, glycemic control, and risk of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Role of anatomic architecture in sustained atrial reentry and double potentials

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Natural and evoked atrial flutter due to circus movement in dogs. Role of abnormal atrial pathways, slow conduction, nonuniform refractory period distribution and premature beats

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry)

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Activation patterns in experimental canine atrial flutter produced by right atrial crush injury

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Increasing prevalence of atrial fibrillation and flutter in the United States

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Quality of life in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial cardiomyocyte tachycardia alters cardiac fibroblast function: a novel consideration in atrial remodeling

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

S4153R is a gain-of-function mutation in the cardiac Ca(2+) release channel ryanodine receptor associated with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The emerging role of biomarkers in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Management of atrial fibrillation in the year 2033: new concepts, tools, and applications leading to personalized medicine

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Value of magnetic resonance imaging in guiding atrial fibrillation management

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Incident atrial fibrillation and mortality in older adults with heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cell size and communication: role in structural and electrical development and remodeling of the heart

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Markers of inflammation before and after curative ablation of atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation and the risk of incident dementia: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Obesity results in progressive atrial structural and electrical remodeling: Implications for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Relation of atrial arrhythmia-related symptoms to health-related quality of life in patients with newly diagnosed atrial fibrillation: a community hospital-based cohort.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Endurance sports is a risk factor for atrial fibrillation after ablation for atrial flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Sport practice and the risk of lone atrial fibrillation: A case–control study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Improving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trial

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

A population-based study of mortality among patients with atrial fibrillation or flutter

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Electrical, contractile and structural remodeling during atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian Trial of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

New ideas about atrial fibrillation 50 years on.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Variants conferring risk of atrial fibrillation on chromosome 4q25.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Therapy Insight: interactions between atrial fibrillation and obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

KATP channel mutation confers risk for vein of Marshall adrenergic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Long-lasting sport practice and lone atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Grown-up congenital heart disease--medical demands look back, look forward 2000

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Epidemiologic features of chronic atrial fibrillation: the Framingham study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Identification of a genetic locus for familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Rhythm control versus rate control for atrial fibrillation and heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Subclinical Atrial Fibrillation and the Risk of Stroke

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Subclinical hyperthyroidism as a risk factor for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Transforming growth factor-β and oxidative stress mediate tachycardia-induced cellular remodelling in cultured atrial-derived myocytes.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Familial aggregation of atrial fibrillation in Iceland

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Early management of atrial fibrillation to prevent cardiovascular complications

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Predictive value of obstructive sleep apnoea assessed by the Berlin Questionnaire for outcomes after the catheter ablation of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Role of inflammation in early atrial fibrillation recurrence

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevalence of unknown atrial fibrillation in patients with risk factors

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Supraventricular tachycardia causing heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Dementia in subjects with atrial fibrillation: hemostatic function and the role of anticoagulation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

SCN5A mutation associated with cardiac conduction defect and atrial arrhythmias

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

KCNQ1 gain-of-function mutation in familial atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Lone atrial fibrillation in vigorously exercising middle aged men: case-control study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prospective cohort study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Quality of life in patients with silent atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Arterial oxygen desaturation during sleep and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Anisotropic conduction properties in canine atria analyzed by high-resolution optical mapping: preferential direction of conduction block changes from longitudinal to transverse with increasing age

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial ischemia promotes atrial fibrillation in dogs

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Locus for atrial fibrillation maps to chromosome 6q14-16

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Intra-Atrial Pressure Increases Rate and Organization of Waves Emanating From the Superior Pulmonary Veins During Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Association of atrial fibrillation and obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial remodeling and atrial fibrillation: mechanisms and implications.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Familial aggregation of atrial fibrillation: a study in Danish twins

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Genetics of atrial fibrillation: implications for future research directions and personalized medicine

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Left atrial epicardial adiposity and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Regular physical activity and risk of atrial fibrillation: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

The natural history of preclinical diastolic dysfunction: a population-based study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cognitive function and anticoagulation control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Physical activity and the risk of incident atrial fibrillation in women

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Myofibroblasts induce ectopic activity in cardiac tissue

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Arrhythmias in adult patients with congenital heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Independent susceptibility markers for atrial fibrillation on chromosome 4q25.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Noninvasive Characterization of Epicardial Activation in Humans With Diverse Atrial Fibrillation Patterns

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Mechanisms of atrial tachyarrhythmias associated with coronary artery occlusion in a chronic canine model

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation pathophysiology: implications for management.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Recent advances in the molecular pathophysiology of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Economic burden and co-morbidities of atrial fibrillation in a privately insured population

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Atrial fibrillation and cognitive decline: a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

A mathematical model of electrotonic interactions between ventricular myocytes and fibroblasts

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in two-dimensional cardiac monolayers.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Arrhythmias in adult congenital heart disease

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cost-effectiveness of rhythm versus rate control in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

Cognitive impairment associated with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1161%2FCIRCRESAHA.114.303211

7 January 2021

10.1161/CIRCRESAHA.114.303211

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24763464%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017